美女免费一级视频在线观看

    • <form id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></form>
      <address id=BiMYPaeIF><nobr id=BiMYPaeIF><nobr id=BiMYPaeIF></nobr></nobr></address>

      Gold
      




      UCB and Area 23   
      Inaction Figures
      




      Nr-axSpA, a rare rheumatoid condition, is a devious villain. It is ravaging millions of people worldwide, causing severe and debilitating back pain, stiffness and inflammation. It’s also cunning, and because it mimics so many other diseases, patients are often left undiagnosed, misdiagnosed and in pain for up to 10 years.
      




      Because the condition is relatively uncommon, rheumatologists do not routinely test for Nr-axSpA early in their diagnostic plan. Until recently, there wasn’t even a billing code for this condition, so even HCPs who recognized it couldn’t provide the appropriate treatment.
      




      To dramatize that suffering for rheumatologists and to encourage them to test for Nr-axSpA, the team created “inaction figures,” drawn from real patient stories combined with Dopl’s 360-degree motion capture technology and 3D printing. These 3D figurines, Delayed Diagnosis Dave, Misdiagnosed Melissa, Bio-Naïve Nick and Bio-Experienced Emily, are stiff, immobile and inflexible. They can’t move a plastic muscle, much like patients caught in the clutches of Nr-axSpA.
      




      The team introduced the figures with custom packaging at one of the nation’s largest rheumatology conventions. It invited providers to “play” with each inflexible figurine. And when rheumatologists realized how little they could do with the dolls, they were directed to interact with a digital experience that gave them more insight into this condition.
      




      After the convention, sales reps continued to use the figurines in sales calls and Lunch and Learns. Although the Inaction Figures are immobile, they moved providers and payers, who are finally beginning to recognize the plight of their patients.
      




      




      Silver
      




      AstraZeneca and VML Health
      It’s Time to Rescue Rescue
      




      Specialists know that albuterol-only rescue inhalers, the standard of care for asthma patients for over 40 years, aren’t enough. These treatments don’t address inflammation, an underlying cause of exacerbations, leaving patients at risk: About half of patients exacerbate yearly. This visual aid challenges PCPs, pulmonologists and allergists to rescue this underperforming category by displaying asthma attack data and depicting the unpredictable rise in inflammation in a graphic format. HCPs gained an understanding of the limitations of albuterol-only rescue, with 71% of specialists agreeing that asthma patients need more.
      




      Click here to view 2024 MM+M Award Winners.